questionsmedicales.fr
Maladies métaboliques et nutritionnelles
Maladies métaboliques
Dermatoses métaboliques
Dermatoses métaboliques : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Dermatoses métaboliques : Questions médicales les plus fréquentes",
"headline": "Dermatoses métaboliques : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Dermatoses métaboliques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-15",
"dateModified": "2025-02-09",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Dermatoses métaboliques"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladies métaboliques",
"url": "https://questionsmedicales.fr/mesh/D008659",
"about": {
"@type": "MedicalCondition",
"name": "Maladies métaboliques",
"code": {
"@type": "MedicalCode",
"code": "D008659",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Lipodystrophie",
"alternateName": "Lipodystrophy",
"url": "https://questionsmedicales.fr/mesh/D008060",
"about": {
"@type": "MedicalCondition",
"name": "Lipodystrophie",
"code": {
"@type": "MedicalCode",
"code": "D008060",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.880.391"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Lipodystrophie généralisée congénitale",
"alternateName": "Lipodystrophy, Congenital Generalized",
"url": "https://questionsmedicales.fr/mesh/D052497",
"about": {
"@type": "MedicalCondition",
"name": "Lipodystrophie généralisée congénitale",
"code": {
"@type": "MedicalCode",
"code": "D052497",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.880.391.550"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Lipodystrophie partielle familiale",
"alternateName": "Lipodystrophy, Familial Partial",
"url": "https://questionsmedicales.fr/mesh/D052496",
"about": {
"@type": "MedicalCondition",
"name": "Lipodystrophie partielle familiale",
"code": {
"@type": "MedicalCode",
"code": "D052496",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.880.391.700"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Nécrobiose lipoïdique",
"alternateName": "Necrobiosis Lipoidica",
"url": "https://questionsmedicales.fr/mesh/D009335",
"about": {
"@type": "MedicalCondition",
"name": "Nécrobiose lipoïdique",
"code": {
"@type": "MedicalCode",
"code": "D009335",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.880.495"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Dermatoses métaboliques",
"alternateName": "Skin Diseases, Metabolic",
"code": {
"@type": "MedicalCode",
"code": "D012875",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Christoph Schlapbach",
"url": "https://questionsmedicales.fr/author/Christoph%20Schlapbach",
"affiliation": {
"@type": "Organization",
"name": "Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland."
}
},
{
"@type": "Person",
"name": "Hans-Uwe Simon",
"url": "https://questionsmedicales.fr/author/Hans-Uwe%20Simon",
"affiliation": {
"@type": "Organization",
"name": "Institute of Pharmacology, University of Bern, Bern, Switzerland."
}
},
{
"@type": "Person",
"name": "Dagmar Simon",
"url": "https://questionsmedicales.fr/author/Dagmar%20Simon",
"affiliation": {
"@type": "Organization",
"name": "Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. dagmar.simon@insel.ch."
}
},
{
"@type": "Person",
"name": "Ashley E Brown",
"url": "https://questionsmedicales.fr/author/Ashley%20E%20Brown",
"affiliation": {
"@type": "Organization",
"name": "McGovern Medical School, University of Texas Health Science Center at Houston,Houston, Texas, USA. Electronic address: Ashley.brown@uth.tmc.edu."
}
},
{
"@type": "Person",
"name": "Connie C Qiu",
"url": "https://questionsmedicales.fr/author/Connie%20C%20Qiu",
"affiliation": {
"@type": "Organization",
"name": "Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Brain microstructural alterations of depression in Parkinson's disease: A systematic review of diffusion tensor imaging studies.",
"datePublished": "2022-07-20",
"url": "https://questionsmedicales.fr/article/35855597",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/hbm.26015"
}
},
{
"@type": "ScholarlyArticle",
"name": "Diffusion Tensor Imaging as a Tool to Evaluate the Cognitive Function of Patients With Vascular Dementia: A Meta-Analysis.",
"datePublished": "2023-05-01",
"url": "https://questionsmedicales.fr/article/35986673",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/NRL.0000000000000461"
}
},
{
"@type": "ScholarlyArticle",
"name": "Diffusion tensor imaging and quantitative T2 mapping to monitor muscle recovery following hamstring injury.",
"datePublished": "2023-01-28",
"url": "https://questionsmedicales.fr/article/36630472",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/nbm.4902"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Diffusion Tensor Imaging-Based Prognostic Classification for Surgery of Intrinsic Lesions Involving the Motor Pathways.",
"datePublished": "2023-01-24",
"url": "https://questionsmedicales.fr/article/36706980",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.wneu.2023.01.081"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comparison of region-of-interest delineation methods for diffusion tensor imaging in patients with cervical spondylotic radiculopathy.",
"datePublished": "2022-07-15",
"url": "https://questionsmedicales.fr/article/35840941",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12891-022-05639-5"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies métaboliques et nutritionnelles",
"item": "https://questionsmedicales.fr/mesh/D009750"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies métaboliques",
"item": "https://questionsmedicales.fr/mesh/D008659"
},
{
"@type": "ListItem",
"position": 4,
"name": "Dermatoses métaboliques",
"item": "https://questionsmedicales.fr/mesh/D012875"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Dermatoses métaboliques - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Dermatoses métaboliques",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Dermatoses métaboliques",
"description": "Comment diagnostiquer une dermatoses métabolique ?\nQuels tests sont utilisés pour le diagnostic ?\nLes dermatoses métaboliques sont-elles héréditaires ?\nQuels signes cliniques indiquent une dermatoses métabolique ?\nPeut-on confondre ces dermatoses avec d'autres maladies ?",
"url": "https://questionsmedicales.fr/mesh/D012875?mesh_terms=Diffusion+Tensor+Imaging&page=6#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Dermatoses métaboliques",
"description": "Quels sont les symptômes courants des dermatoses métaboliques ?\nLes démangeaisons sont-elles fréquentes ?\nY a-t-il des signes de gravité à surveiller ?\nLes symptômes varient-ils selon le type de maladie ?\nPeut-on avoir des symptômes systémiques ?",
"url": "https://questionsmedicales.fr/mesh/D012875?mesh_terms=Diffusion+Tensor+Imaging&page=6#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Dermatoses métaboliques",
"description": "Comment prévenir les dermatoses métaboliques ?\nLes facteurs environnementaux jouent-ils un rôle ?\nEst-il possible de prévenir les complications ?\nLes habitudes de vie influencent-elles ces maladies ?\nFaut-il éviter certains aliments ?",
"url": "https://questionsmedicales.fr/mesh/D012875?mesh_terms=Diffusion+Tensor+Imaging&page=6#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Dermatoses métaboliques",
"description": "Quels traitements sont disponibles pour ces dermatoses ?\nLes traitements sont-ils personnalisés ?\nLes traitements sont-ils efficaces ?\nY a-t-il des effets secondaires aux traitements ?\nLes traitements nécessitent-ils un suivi régulier ?",
"url": "https://questionsmedicales.fr/mesh/D012875?mesh_terms=Diffusion+Tensor+Imaging&page=6#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Dermatoses métaboliques",
"description": "Quelles complications peuvent survenir ?\nLes dermatoses métaboliques peuvent-elles affecter la qualité de vie ?\nComment gérer les complications ?\nLes complications sont-elles réversibles ?\nLes complications peuvent-elles être évitées ?",
"url": "https://questionsmedicales.fr/mesh/D012875?mesh_terms=Diffusion+Tensor+Imaging&page=6#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Dermatoses métaboliques",
"description": "Quels sont les principaux facteurs de risque ?\nL'obésité est-elle un facteur de risque ?\nLe stress influence-t-il ces maladies ?\nLes maladies chroniques augmentent-elles le risque ?\nL'âge est-il un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D012875?mesh_terms=Diffusion+Tensor+Imaging&page=6#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dermatoses métabolique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen clinique, les antécédents médicaux et des tests de laboratoire."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses sanguines, des biopsies cutanées et des tests génétiques peuvent être nécessaires."
}
},
{
"@type": "Question",
"name": "Les dermatoses métaboliques sont-elles héréditaires ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines dermatoses métaboliques ont une composante génétique, mais pas toutes."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent une dermatoses métabolique ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des lésions cutanées atypiques, des démangeaisons et des changements de pigmentation peuvent indiquer une maladie."
}
},
{
"@type": "Question",
"name": "Peut-on confondre ces dermatoses avec d'autres maladies ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent être confondues avec d'autres affections cutanées, nécessitant un diagnostic précis."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des dermatoses métaboliques ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des éruptions cutanées, des démangeaisons et des changements de texture."
}
},
{
"@type": "Question",
"name": "Les démangeaisons sont-elles fréquentes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les démangeaisons sont un symptôme courant et peuvent varier en intensité."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes de gravité à surveiller ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme des infections secondaires ou des lésions étendues nécessitent une attention médicale."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de maladie ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier considérablement selon le type de dermatoses métaboliques."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes systémiques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines dermatoses métaboliques peuvent être associées à des symptômes systémiques comme la fatigue."
}
},
{
"@type": "Question",
"name": "Comment prévenir les dermatoses métaboliques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée, l'exercice régulier et un suivi médical peuvent aider à prévenir."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux jouent-ils un rôle ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains facteurs environnementaux peuvent exacerber les dermatoses métaboliques."
}
},
{
"@type": "Question",
"name": "Est-il possible de prévenir les complications ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un traitement précoce et un suivi régulier peuvent aider à prévenir les complications."
}
},
{
"@type": "Question",
"name": "Les habitudes de vie influencent-elles ces maladies ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des habitudes de vie saines peuvent réduire le risque de développer des dermatoses métaboliques."
}
},
{
"@type": "Question",
"name": "Faut-il éviter certains aliments ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains aliments peuvent aggraver les symptômes, il est conseillé de les éviter."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour ces dermatoses ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des crèmes topiques, des médicaments systémiques et des thérapies ciblées."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le traitement est souvent adapté en fonction du type de dermatoses et des symptômes."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils efficaces ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité varie selon le type de dermatoses et la réponse individuelle au traitement."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires aux traitements ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains traitements peuvent avoir des effets secondaires, nécessitant un suivi médical."
}
},
{
"@type": "Question",
"name": "Les traitements nécessitent-ils un suivi régulier ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi régulier est souvent nécessaire pour ajuster le traitement et surveiller les progrès."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des infections cutanées, des cicatrices et des troubles psychologiques."
}
},
{
"@type": "Question",
"name": "Les dermatoses métaboliques peuvent-elles affecter la qualité de vie ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent avoir un impact significatif sur la qualité de vie et le bien-être psychologique."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des complications nécessite souvent une approche multidisciplinaire et un suivi médical."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié, d'autres non."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être évitées ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un traitement précoce et un suivi régulier peuvent aider à éviter certaines complications."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des désordres métaboliques et des habitudes alimentaires."
}
},
{
"@type": "Question",
"name": "L'obésité est-elle un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'obésité est un facteur de risque connu pour plusieurs dermatoses métaboliques."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il ces maladies ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut aggraver les symptômes et augmenter le risque de dermatoses métaboliques."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques augmentent-elles le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies chroniques peuvent augmenter le risque de développer des dermatoses métaboliques."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains types de dermatoses métaboliques sont plus fréquents chez les personnes âgées."
}
}
]
}
]
}
Depression, a leading cause of disability worldwide, is also the most prevalent psychiatric problem among Parkinson disease patients. Both depression and Parkinson disease are associated with microstr...
Vascular dementia (VaD) is the most common type of dementia secondary to Alzheimer's disease. The pathologic mechanism of VaD is complex, and VaD still lacks a more objective diagnosis and evaluation ...
Authors searched Pubmed, Embase, and Cochrane Library, using the search terms, such as "diffusion tensor imaging," "DTI," "Vascular Dementia," "Arteriosclerotic Dementia," "Cognition," and "Cognitive....
A total of 8 case-control studies were included in this meta-analysis. The sample size of patients ranged from 35 to 60, including 166 patients in the VaD group and 177 healthy individuals. The DTI im...
DTI imaging of the brain tissue of VaD patients was clearly different from that of healthy controls. Therefore it may be feasible to use DTI imaging as a diagnostic method for VaD....
MRI examinations are accurate for diagnosing sports-related acute hamstring injuries. However, sensitive imaging methods for assessing recovery of these injuries are lacking. Diffusion tensor imaging ...
The critical role of different adjuncts in improving the neurological outcome in intrinsic brain lesions affecting eloquent areas is demonstrated by their more diffuse utilization. Neurosurgeons often...
We included patients consecutively enrolled at our institution between April 2020 and September 2022 with 3 patterns of increasing complexity according to the relationship between the lesion and the c...
The study included 83 patients. A statistically significant linear trend between higher rates of reduction of MEPs and higher classification grades was observed (P = 0.001), with sensitivity 0.60, spe...
The classification proved reliable in anticipating reduction in intraoperative MEPs and in predicting neurological outcome. Using this classification in patients undergoing surgery for lesions involvi...
Diffusion tensor imaging is a promising technique for determining the responsible lesion of cervical radiculopathy, but the selection and delineation of the region of interest (ROI) affect the results...
This retrospective study included CSR patients who underwent DTI imaging. The images were analyzed independently by two radiologists. Four delineation methods were used: freehand method, maximum round...
Forty-two CSR patients were included in this study. The distribution of the compressed nerve roots was five C4, eight C5, sixteen C6, eleven C7, and two C8. No differences were found among the four me...
The freehand and single largest circle methods were the most consistent methods for delineating DTI ROI in patients with CSR....
The therapeutic advance in hereditary transthyretin amyloidosis (ATTRv amyloidosis) requires quantitative biomarkers of nerve involvement in order to foster early diagnosis and monitor therapy respons...
Alzheimer's disease (AD) is a degenerative neurological disease in elderly individuals. Subjective cognitive decline (SCD), mild cognitive impairment (MCI) and further development to dementia (d-AD) a...
The purpose of this study was to examine the values of fractional anisotropy (FA) and apparent diffusion coefficient (ADC) in diffusion tensor imaging (DTI) for diagnosing patients with nerve impairme...
A literature search of databases (PubMed, Web of Science, Cochrane Library and Embase) was systematically performed to identify articles published before September 2021 that were relevant to this stud...
A total of 369 patients with LDH from 11 publications were included in this meta-analysis. The results showed significantly lower FA values (Weighted Mean Difference (WMD): -0.08, 95% confidence inter...
This meta-analysis showed a significant decrease in FA and a significant increase in ADC in patients with nerve damage due to LDH. The results favourably support the presence of nerve impairment in pa...
Patients with obstructive sleep apnea (OSA) show autonomic, mood, cognitive, and breathing dysfunctions that are linked to increased morbidity and mortality, which can be improved with early screening...
White matter (WM) degeneration is suggested to predict the early signs of Alzheimer's disease (AD). The exact structural regions of brain circuitry involved are not known. This study aims to examine t...